ASCO Breast Cancer
Conference Coverage
Inavolisib Added to Standard Tx Shows Sustained Benefit in Advanced BC
An expanded analysis of the INAVO120 trial looks at time from randomization to end of next-line treatment, time to first chemotherapy, and patient...
Latest News
Surviving to Thriving: Enhancing Quality of Life in Breast Cancer
Up to 90% of early breast cancer survivors experience long-term effects from treatment, which often include fatigue, loss of mobility, chronic...
Conference Coverage
T-DXd Moves Toward First Line for HER2-Low Metastatic BC
New results from DESTINY trials support use of the antibody-drug conjugate earlier in the treatment algorithm for cancers expressing even the...
Conference Coverage
Anti-Müllerian Hormone Predicts Chemo Benefits in BC
Hormone level measures may help some patients with HR+/HER2- invasive breast cancer avoid chemotherapy.
Feature
Should ER-Low Breast Cancer Patients Be Offered Endocrine Therapy?
New evidence suggests that omitting endocrine therapy increases the risk of death in this patient group.
Conference Coverage
Abemaciclib Plus Fulvestrant Improves Survival in Advanced Breast Cancer
A switch to a different CDK therapy addressed an unmet need for HR positive, HER2 negative advance breast cancer patients.
Conference Coverage
Most women can conceive after breast cancer treatment
In a modern cohort of patients under 40 without metastatic disease, financial status and egg or embryo freezing — but not chemotherapy — affected...
Latest News
Is Vaginal Estrogen Safe in Breast Cancer Survivors?
Study results suggest that estrogen therapy “is safe in individuals with HR-negative tumors and in those concurrently treated with tamoxifen.”
Latest News
ASCO Releases Vaccination Guidelines for Adults With Cancer
Oncologists may be key in ensuring patients with cancer safely receive vaccinations and avert avoidable infections.
Conference Coverage
Select patients with breast cancer may skip RT after lumpectomy
There is “clearly a population of early-stage breast cancer [patients] who after lumpectomy do not benefit from radiation.”
The Practicing Oncologist
My picks for best of ASCO 2022
First-line treatment for colorectal cancer, possible new standard of care for breast cancer, and more.